Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment

Dermatology

Volumn 218, Issue 4, 2009, Pages 338-341

  Rigopoulos, D ^a   Gregoriou, S ^a   Daniel III, C R ^b   Belyayeva, H ^a   Larios, G ^a   Verra, P ^a   Stamou, C ^a   Kontochristopoulos, G ^a   Avgerinou, G ^a   Katsambas, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Betamethasone; Calcipotriol; Nail psoriasis; Nail psoriasis severity index

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; HYPERKERATOSIS; MALE; NAIL DISEASE; NAIL PSORIASIS; ONYCHOLYSIS; OPEN STUDY; PRIORITY JOURNAL; PSORIASIS; SKIN IRRITATION;

BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; HUMANS; NAIL DISEASES; OINTMENTS; PSORIASIS;

EID: 67651100455     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000202179     Document Type: Article

References (14)

1. De Berker D: Diagnosis and management of nail psoriasis. Dermatol Ther 2002; 15: 165-172.
2. De Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC: Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303. (Pubitemid 27007572)
3. McGonagle D, Tan L, Benjamin M: The nail as a muscloskeletal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology, in press.
4. Gregoriou S, Kalogeromitros D, Kosionis N, Gkouvi A, Rigopoulos D: Treatment options for nail psoriasis. Exp Rev Dermatol 2008; 3: 339-344.
5. Rich P, Scher RK: Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212. (Pubitemid 36951265)
6. de Berker DA, Lawrence CM: A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998; 138: 90-95.
7. Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B: Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology 2003; 206: 153-156. (Pubitemid 36205284)
8. Scher RK, Stiller M, Zhu YI: Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001; 68: 355-358. (Pubitemid 33756739)
9. Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MC, Guzzo C: Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231.
10. Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, Benelli C: Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139: 655-659. (Pubitemid 28474312)
11. Piraccini BM, Tosti A, Iorizzo M, Misciali C: Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients. Br J Dermatol 2001; 144: 1000-1005. (Pubitemid 34203353)
12. Rigopoulos D, Ioannides D, Prastitis N, Katsambas A: Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Dermatol Venereol 2002; 82: 140. (Pubitemid 34596692)
13. Luger TA, Cambazard F, Larsen FG, et al: A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology 2008; 217: 321-328.
14. Augustin M, Peeters P, Radtke M, Moehling U, Lapp C: Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany: a comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone. Dermatology 2007; 215: 219-228. (Pubitemid 47378989)